Discontinuation report TEVA-VENLAFAXINE XR
Report ID | 117546 |
Drug Identification Number | 02275023 |
Brand name | TEVA-VENLAFAXINE XR |
Common or Proper name | VENLAFAXINE XR 37.5MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VENLAFAXINE |
Strength(s) | 37.5MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-06-08 |
Remaining supply date | 2020-06-08 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Transitioned TEVA product to ACT-VENLAFAXINE. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-06-11 | French | Compare |
v1 | 2020-06-11 | English | Compare |
Showing 1 to 2 of 2